Clinically-approved CFTR modulators rescue Nrf2 dysfunction in cystic fibrosis airway epithelia

Dana C Borcherding1, Matthew E Siefert1, Songbai Lin1,2

  • 1Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Insights

Cystic Fibrosis (CF) drug VX809/VX661 restores nuclear-factor-E2-related factor-2 (Nrf2) function in CF cells. This correction is linked to improved cystic fibrosis transmembrane conductance regulator (CFTR) function, highlighting a new therapeutic target.

Area of Science:

  • Cell Biology
  • Genetics
  • Molecular Medicine

Background:

  • Cystic Fibrosis (CF) is a genetic disorder caused by dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) protein.
  • Nuclear-factor-E2-related factor-2 (Nrf2), a key regulator of cellular defense mechanisms, is impaired in CF.

Purpose of the Study:

  • To investigate if CFTR correctors can restore Nrf2 function in CF.
  • To elucidate the mechanism by which CFTR correctors impact Nrf2 activity.

Main Methods:

  • Proximity ligation assay, immunoprecipitation, and immunofluorescence were used to assess Nrf2 and CFTR colocalization.
  • Nrf2-dependent reporter gene assays and target gene expression analysis were performed.
  • Experiments involved primary human bronchial epithelial cells from CF patients and CFTR knockdown models.

Main Results:

  • CFTR correctors VX809/VX661 restored Nrf2 function and its colocalization with CFTR in CF cells.
  • These correctors promoted Nrf2 nuclear translocation and transcriptional activity.
  • Nrf2 rescue was dependent on CFTR correction and functional channel activity.

Conclusions:

  • Modulation of F508del-CFTR function by approved correctors can restore Nrf2 dysfunction in Cystic Fibrosis.
  • This suggests a direct link between CFTR function and redox/inflammatory signaling pathways regulated by Nrf2.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
743
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
248
Suctioning the Oropharyngeal Airway01:25

Suctioning the Oropharyngeal Airway

In preparing for oropharyngeal airway suctioning, a nurse must gather all necessary equipment, including a suction unit with tubing, a prepackaged suction kit, sterile gloves, water or saline for irrigation, a water-soluble lubricant, and additional personal protective equipment (such as a gown, mask, and goggles) to control infections.
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
862
Suctioning the Nasopharyngeal Airway01:29

Suctioning the Nasopharyngeal Airway

Nasopharyngeal suctioning is a procedure to remove secretions from the upper part of the respiratory tract that the patient cannot clear independently. It helps maintain airway patency and prevents complications such as aspiration pneumonia.
Equipment Required
3.2K
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
592